Kawasaki Disease Conjunctival Injection

What is Kawasaki Disease Conjunctival Injection?

Conjunctival injection, often described as “bloodshot eyes,” is a hallmark sign of Kawasaki disease (KD). Kawasaki disease is an acute, self‑limited vasculitis that primarily affects children under five years of age. The term conjunctival injection refers to the diffuse redness of the bulbar conjunctiva caused by inflammation of the tiny blood vessels within the eye. In KD, this redness is typically non‑exudative (no pus or discharge) and involves both eyes simultaneously.

Early recognition of conjunctival injection, together with other clinical criteria, is crucial because untreated KD can lead to serious coronary artery complications. The condition is named after Dr. Tomisaku Kawasaki, who first described it in Japan in 1967.

Common Causes

While Kawasaki disease is the classic cause of bilateral non‑exudative conjunctival injection in children, several other conditions can produce a similar red‑eye appearance. Below are 8–10 common causes:

• Viral conjunctivitis – adenovirus, enterovirus, or influenza.
• Bacterial conjunctivitis – Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae.
• Allergic conjunctivitis – pollen, animal dander, or dust mite exposure.
• Uveitis – autoimmune or infectious (e.g., juvenile idiopathic arthritis, sarcoidosis).
• Dry eye syndrome – especially in older children or those using digital devices extensively.
• Contact lens irritation – mechanical trauma or hypoxia.
• Subconjunctival hemorrhage – trauma or sudden increase in venous pressure.
• Systemic vasculitides – e.g., Henoch‑Schönlein purpura, polyarteritis nodosa.
• Medication side‑effects – topical prostaglandin analogues used for glaucoma.
• Environmental irritants – smoke, chlorine, or chemical splashes.

Associated Symptoms

In Kawasaki disease, conjunctival injection rarely occurs in isolation. Other typical findings include:

• Fever lasting ≥5 days (often >39 °C/102.2 °F).
• Oral mucosal changes – cracked lips, strawberry tongue, erythematous or “fiery” pharynx.
• Extremity changes – swollen hands/feet, erythema, later desquamation (peeling) of fingertips.
• Polymorphous rash – often truncal, non‑vesicular.
• Cervical lymphadenopathy – usually unilateral, ≥1.5 cm.
• Changes in cardiac function – murmurs, gallops, or evidence of coronary artery dilation on echo.

When the redness is due to other etiologies, accompanying signs may differ (e.g., purulent discharge in bacterial conjunctivitis, itching in allergic conjunctivitis).

When to See a Doctor

Because Kawasaki disease can evolve quickly and affect the heart, prompt medical evaluation is essential. Seek professional care if you notice:

• Fever that has persisted for more than 3 days without a clear cause.
• Redness in both eyes that does not improve within 24–48 hours.
• Any combination of the classic KD features listed above.
• New or worsening rash, swollen hands/feet, or painful lymph nodes.
• Persistent eye irritation accompanied by photophobia, pain, or visual changes.

Even if you suspect a simple conjunctivitis, children under five with bilateral redness should be evaluated to rule out KD.

Diagnosis

Diagnosing Kawasaki disease conjunctival injection involves a stepwise approach:

Clinical Evaluation

• History – duration of fever, exposure to sick contacts, recent vaccinations, medication use.
• Physical Exam – careful inspection of both eyes for diffuse non‑exudative redness, assessment for the other four principal KD criteria, and measurement of lymph node size.

Laboratory Tests

While no single test confirms KD, several labs support the diagnosis and assess severity:

• Complete blood count (CBC) – often shows neutrophilia and mild anemia.
• Elevated acute‑phase reactants: C‑reactive protein (CRP) and erythrocyte sedimentation rate (ESR).
• Urinalysis – sterile pyuria may be present.
• Liver enzymes (ALT/AST) – modest elevation in some cases.

Imaging

• Echocardiography – the gold standard for detecting coronary artery aneurysms or dilation; repeated at 2 weeks and 6–8 weeks after onset.
• Chest X‑ray or abdominal ultrasound is rarely needed unless complications are suspected.

Differential Diagnosis

Physicians will rule out other causes of bilateral conjunctival redness (viral/bacterial conjunctivitis, allergic reactions, systemic vasculitis) based on history, exam, and targeted testing.

Treatment Options

Early treatment markedly reduces the risk of coronary artery aneurysms (down from ~25 % to <5 %). Management includes both hospital‑based medical therapy and supportive home care.

Medical Therapy

• Intravenous Immunoglobulin (IVIG) – 2 g/kg given as a single infusion within the first 10 days of illness; the cornerstone of KD treatment.
• Aspirin – high‑dose (80–100 mg/kg/day) during the acute febrile phase, then low‑dose (3–5 mg/kg/day) for antiplatelet effect until 6–8 weeks after fever resolves and coronary arteries are normal on echo.
• Corticosteroids – added for IVIG‑resistant cases or in patients at high risk for coronary complications (e.g., infants <6 months, persistent fever after initial IVIG).
• Biologic agents – infliximab or anakinra in refractory KD, based on emerging evidence.

Supportive Home Care

• Maintain adequate hydration; fever can increase fluid loss.
• Cool compresses or artificial tears may soothe eye discomfort, but avoid over‑the‑counter eye drops unless prescribed.
• Acetaminophen or ibuprofen for comfort (do not replace aspirin therapy prescribed by a physician).
• Monitor temperature and watch for new symptoms; keep a log of fever spikes and any changes in rash or eye appearance.

Prevention Tips

Because the exact trigger of Kawasaki disease remains unknown, primary prevention is limited. However, certain measures can reduce the risk of secondary infections and complications:

• Practice good hand hygiene, especially in daycare or school settings.
• Avoid exposing children to known respiratory viruses during peak seasons.
• Ensure up‑to‑date vaccinations, which may lower overall viral load in the community.
• Promptly treat any bacterial conjunctivitis to avoid ocular inflammation that could mimic KD.
• Seek immediate medical care for any prolonged fever in a child under five years old.

Emergency Warning Signs

References

• Mayo Clinic. “Kawasaki disease.” https://www.mayoclinic.org.
• American Heart Association. “Diagnosis, Treatment, and Management of Kawasaki Disease.” 2020 Scientific Statement.
• Centers for Disease Control and Prevention. “Kawasaki Disease.” https://www.cdc.gov.
• National Institutes of Health, National Heart, Lung, and Blood Institute. “Kawasaki Disease.” https://www.nhlbi.nih.gov.
• Cleveland Clinic. “Kawasaki Disease in Children.” https://my.clevelandclinic.org.
• World Health Organization. “Guidelines for the Management of Kawasaki Disease.” 2022.